Revelation Biosciences Inc (NASDAQ:REVB) has a beta value of 0.20 and has seen 2.33 million shares traded in the last trading session. The company, currently valued at $2.05M, closed the last trade at $0.25 per share which meant it lost -$0.07 on the day or -23.84% during that session. The REVB stock price is -10004.0% off its 52-week high price of $25.26 and -12.0% below the 52-week low of $0.28. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.75 million shares traded. The 3-month trading volume is 3.24 million shares.
The consensus among analysts is that Revelation Biosciences Inc (REVB) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.43.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Sporting -23.84% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the REVB stock price touched $0.25 or saw a rise of 42.67%. Year-to-date, Revelation Biosciences Inc shares have moved -46.72%, while the 5-day performance has seen it change -40.73%. Over the past 30 days, the shares of Revelation Biosciences Inc (NASDAQ:REVB) have changed -16.75%. Short interest in the company has seen 0.24 million shares shorted with days to cover at 0.1.
Revelation Biosciences Inc (REVB) estimates and forecasts
Figures show that Revelation Biosciences Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -85.12% over the past 6 months, with this year growth rate of 79.76%, compared to 16.40% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
Earnings growth for 2025 is a modest -1311.32% while over the next 5 years, the company’s earnings are expected to decrease by -23.98%.
REVB Dividends
Revelation Biosciences Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Insiders own 0.03% of the company shares, while shares held by institutions stand at 11.37% with a share float percentage of 11.37%. Investors are also buoyed by the number of investors in a company, with Revelation Biosciences Inc having a total of 9.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund . As of Nov 30, 2024 , the former fund manager holds about 0.10% shares in the company for having 8.02 shares of worth $1970.0 while later fund manager owns 2.94 shares of worth $722.0 as of Nov 30, 2024 , which makes it owner of about 0.04% of company’s outstanding stock.
